CAS 1002101-19-0

Fórmula: C13H18O2

InChI: InChI=1S/C13H18O2/c1-2-3-4-6-11-7-5-8-12(9-11)10-13(14)15/h5,7-9H,2-4,6,10H2,1H3,(H,14,15)

Chave InChI: PEGQOIGYZLJMIB-UHFFFAOYSA-N

SMILES: CCCCCC1=CC(=CC=C1)CC(=O)O

Fezagepras

CAS: 1002101-19-0

Fezagepras (Setogepram) is an orally active GPR40 agonist and is an antagonist or inverse agonist of GPR84 with anti-inflammatory, anti-fibrotic, and anti-

Fórmula: C₁₃H₁₈O₂

Pureza: 97.7% - 99.38%

Cor e Forma: Solid

Peso molecular: 206.28

Ref: TM-T12883

3-Pentylbenzeneacetic acid

CAS: 1002101-19-0

Fórmula: C₁₃H₁₈O₂

Pureza: 96.73%

Cor e Forma: Solid

Peso molecular: 206.2808

Ref: IN-DA00019D

Fezagepras

CAS: 1002101-19-0

Fezagepras

Fórmula: C₁₃H₁₈O₂

Pureza: ≥95%

Peso molecular: 206.28

Ref: 54-BUP04685

Fezagepras

CAS: 1002101-19-0

2-(3-Pentylphenyl)acetic acid

Fórmula: C₁₃H₁₈O₂

Pureza: 97%

Peso molecular: 206.28

Ref: IN-DG01005317

2-(3-Pentylphenyl)acetic acid

CAS: 1002101-19-0

2-(3-Pentylphenyl)acetic acid is a synthetic fatty acid that has been shown to have potent activity in the treatment of chronic kidney disease. It inhibits the production of proinflammatory cytokines and growth factors, leading to decreased inflammation and fibrosis in the kidneys. This compound also prevents insulin resistance, which may be due to its ability to activate insulin receptors. 2-(3-Pentylphenyl)acetic acid is a crystalline polymorph with an activated carbon atom at position C-2 that can undergo conversion into other crystalline forms. The different morphs are distinguished by their physical properties and chemical reactivity.

Fórmula: C₁₃H₁₈O₂

Pureza: Min. 95%

Peso molecular: 206.28 g/mol

Ref: 3D-CQB10119